Skip to main content
Kent Academic Repository

Pharmaceutical policies for gaining access to high-priced medicines: a comparative analysis between England and Brazil

Geison, Vicente, Calnan, Michael .W., Rech, Norberto, Leite, Silvana (2022) Pharmaceutical policies for gaining access to high-priced medicines: a comparative analysis between England and Brazil. Saúde em Debate, 46 (134). pp. 886-905. ISSN 0103-1104. (doi:10.1590/0103-1104202213422) (KAR id:94967)

PDF Author's Accepted Manuscript
Language: English

Restricted to Repository staff only
Contact us about this Publication
[thumbnail of 6785-Texto do artigo-46813-72880-15-20220319.pdf]
Microsoft Word (Word processing document) Author's Accepted Manuscript
Language: English

Restricted to Repository staff only
Contact us about this Publication
[thumbnail of Word processing document]
PDF Publisher pdf
Language: English


Download this file
(PDF/378kB)
[thumbnail of en.pdf]
Preview
Request a format suitable for use with assistive technology e.g. a screenreader
Official URL:
https://www.scielosp.org/article/sdeb/2022.v46n134...

Abstract

Even though the National Health Service (NHS) and Unified Health System (SUS) are systems with similar universal principles, they can show different political measure patterns in the pharmaceutical field. The aim was to provide a comparative analysis of pharmaceutical policies highlighting strategies to guarantee sustainability and access to high-price medicines (HPM) between Brazil and England. An integrative literature review was performed in electronic databases between January 2009 and December 2019, supplemented by grey literature searched in governmental platforms (laws, decrees, ordinances, and resolutions). A total of 47 articles and 7 policies were selected for analysis, categorised according to the lifecycle of a pharmaceutical product framework. The results showed that both countries applied distinct policies to guarantee access to HPM, between them, policies to define prices and reimbursements, and actions to regulate the access and use of these medicines in the health systems. Also, these countries apply distinct policies to their own sustainability. While Brazil often uses partnerships for productive development, England uses a collaborative accelerated access program. In conclusion, despite similarities in the normative principles, these countries have been proposing and applying distinct policies to maintain access to HPM and ensure the sustainability of their health systems.

Item Type: Article
DOI/Identification number: 10.1590/0103-1104202213422
Uncontrolled keywords: Health policy; Technology; High-Cost; Public health
Subjects: H Social Sciences
H Social Sciences > HV Social pathology. Social and public welfare
R Medicine > RM Therapeutics. Pharmacology
Divisions: Divisions > Division for the Study of Law, Society and Social Justice > School of Social Policy, Sociology and Social Research
Funders: University of Kent (https://ror.org/00xkeyj56)
Depositing User: Michael Calnan
Date Deposited: 10 May 2022 15:40 UTC
Last Modified: 09 Jan 2024 23:56 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/94967 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.